13 Myalgic Encephalomyelitis Clinical Trials in Lexington, KY (2026)

Q: How do I join a clinical trial in Lexington?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Lexington research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Lexington

NCT06677112Recruiting

MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer

This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging. This study will gather information to help...

Lexington, KY625 participantsRachel Miller

View Study Details

NCT05548413Recruiting

Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies

People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality of life. In the proposed intervention, nu...

Lexington, KY328 participantsJia-Rong Wu

View Study Details

NCT07226596Recruiting

Non-Abstinence Outcomes in Methamphetamine Use Disorder

Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoi...

Lexington, KY300 participantsWilliam Stoops

View Study Details

NCT05655312Recruiting

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

In this first-in human, phase I/IIa study, the safety and efficacy of \[212Pb\]VMT01, an alpha-particle emitting therapeutic agent targeted to melanocortin sub-type 1 receptor (MC1R) is being evaluate...

Lexington, KY300 participantsPerspective Therapeutics

View Study Details

NCT05219617Recruiting

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

The primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic) compared with placebo in ped...

Lexington, KY252 participantsSK Life Science, Inc.

View Study Details

NCT07281079Recruiting

A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

This Phase 3, randomized, double-blind, parallel-group (2-arm), placebo-controlled, multicenter study will evaluate the efficacy and safety of NNZ-2591 compared to placebo in pediatric participants wi...

Lexington, KY160 participantsNeuren Pharmaceuticals Limited

View Study Details

NCT07087054Recruiting

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

A Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of paltusotine in adults with ca...

Lexington, KY141 participantsCrinetics Pharmaceuticals Inc.

View Study Details

NCT07201519Recruiting

Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

The goal of this clinical trial is to help learn about the safety and feasibility of hepatic artery infusion chemotherapy for those who have colorectal liver metastases, both resectable and unresectab...

Lexington, KY80 participantsMichael J Cavnar, MD

View Study Details

NCT05001880Recruiting

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

This phase II trial compares the usual treatment alone (carboplatin, pemetrexed, and bevacizumab) to using immunotherapy (atezolizumab) plus the usual treatment in treating patients with peritoneal me...

Lexington, KY66 participantsNational Cancer Institute (NCI)

View Study Details

NCT05172245Recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

This phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy ("chemo-radiation") in patients ...

Lexington, KY46 participantsNational Cancer Institute (NCI)

View Study Details

NCT05691465Recruiting

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

This phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places in the body (metastati...

Lexington, KY35 participantsNational Cancer Institute (NCI)

View Study Details

NCT06830980Recruiting

Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH

The purpose of this study is to learn more about how accelerated theta burst stimulation affects methamphetamine craving and brain activity. Theta burst stimulation is a unique transcranial magnetic s...

Lexington, KY30 participantsGopalkumar Rakesh

View Study Details

NCT07194044Recruiting

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

This single arm study is designed to demonstrate the feasibility of a radically different approach for an exceptionally high-risk subset of MES with widely metastatic disease (WMES). We incorporate th...

Lexington, KY15 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Lexington

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 13 myalgic encephalomyelitis clinical trials recruiting participants in Lexington, KY. These studies are seeking a combined 2,378 participants. Research is being sponsored by Rachel Miller, Jia-Rong Wu, William Stoops and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Lexington — FAQ

Are there myalgic encephalomyelitis clinical trials in Lexington?

Yes, there are 13 myalgic encephalomyelitis clinical trials currently recruiting in Lexington, KY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lexington?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lexington research site will contact you about next steps.

Are clinical trials in Lexington free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lexington studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 13 active trials in Lexington are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov